The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trendelenburg, M.
Right arrow Articles by Botto, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trendelenburg, M.
Right arrow Articles by Botto, M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Substance via MeSH
The Journal of Immunology, 2005, 175: 6909-6914.
Copyright © 2005 by The American Association of Immunologists

The Role of Complement in Cryoglobulin-Induced Immune Complex Glomerulonephritis1

Marten Trendelenburg*, Liliane Fossati-Jimack2,*, Josefina Cortes-Hernandez2,*, Daniel Turnberg*, Margarita Lewis{dagger}, Shozo Izui{ddagger}, H. Terence Cook{dagger} and Marina Botto3,*

* Rheumatology Section and {dagger} Department of Histopathology, Faculty of Medicine, Imperial College, London, United Kingdom; and {ddagger} Department of Pathology and Immunology, University Medical Center, University of Geneva, Geneva, Switzerland

Many forms of glomerulonephritis are triggered by Ab localization in the glomerulus, but the mechanisms by which this induces glomerular inflammation are not fully understood. In this study we investigated the role of complement in a mouse model of cryoglobulin-induced immune complex glomerulonephritis. Several complement-deficient mice on a C57BL/6 and BALB/c genetic background were used and compared with strain-matched, wild-type controls. Cryoglobulinemia was induced by i.p. injection of 6-19 hybridoma cells producing an IgG3 cryoglobulin with rheumatoid factor activity against IgG2a of allotype a present in BALB/c, but not C57BL/6, mice. Thus, the cryoprecipitate in C57BL/6 mice consisted of the IgG3 cryoglobulin only (type I cryoglobulinemia) compared with IgG3-IgG2a complexes in BALB/c (type II cryoglobulinemia). The survival of mice was not affected by complement deficiency. Glomerular influx of neutrophils was significantly less in C3-, factor B-, and C5-deficient mice compared with wild-type and C1q-deficient mice. It did not correlate with C3 deposition, but did correlate with the amount of C6 deposited. Deficiency of CD59a, the membrane inhibitor of the membrane attack complex, did not induce an increase in neutrophil infiltration, suggesting that the generation of C5a accounts for the effects observed. There was no apparent difference between cryoglobulinemia types I and II regarding the role of complement. Our results suggest that in this model of cryoglobulin-induced glomerulonephritis the neutrophil influx was mediated by C5 activation with the alternative pathway playing a prominent role in its cleavage. Thus, blocking C5 is a potential therapeutic strategy for preventing renal injury in cryoglobulinemia.




This article has been cited by other articles:


Home page
CJASNHome page
C. E. Alpers and J. Kowalewska
Emerging Paradigms in the Renal Pathology of Viral Diseases
Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(Supplement_1): S6 - S12.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Mihai, M. T. Chiriac, K. Takahashi, J. M. Thurman, V. M. Holers, D. Zillikens, M. Botto, and C. Sitaru
The Alternative Pathway of Complement Activation Is Critical for Blister Induction in Experimental Epidermolysis Bullosa Acquisita
J. Immunol., May 15, 2007; 178(10): 6514 - 6521.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
G. S Braun, S. Horster, K. S Wagner, S. Ihrler, and H. Schmid
Cryoglobulinaemic vasculitis: classification and clinical and therapeutic aspects
Postgrad. Med. J., February 1, 2007; 83(976): 87 - 94.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.